Development and Evolution of a 24-Hour Pharmacist-Coordinated Antimicrobial Stewardship Service in a Community Hospital

Davis, Sondra; Newcomer, Darrell R.; Bhayani, Nikhil

doi:10.1310/hpj4908-685

Cited by 2 publications

(1 citation statement)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Technology can increase the number of antimicrobial interventions, improve access to information remotely, and enhance communication amongst care teams 41–44 . CDSS can also enhance TASP collaboration with the microbiology laboratory 15,45 and allow on‐site and remote clinicians to respond to rapid diagnostic test results promptly, augmenting utility of these stewardship tools. It is ideal to combine technology and CDSS with TASP clinicians to have the greatest impact on patient outcomes and to evaluate the most actionable and meaningful alerts for each unique institution 46,47 …”

Section: Technology and Tele‐antimicrobial Stewardshipmentioning

confidence: 99%

Tele‐antimicrobial stewardship programs: A review of the literature and the role of the pharmacist

Andrzejewski¹,

McCreary

Khadem

et al. 2021

J Am Coll Clin Pharm

View full text Add to dashboard Cite

Antimicrobial overuse and multidrug‐resistant pathogens are growing problems throughout the United States, yet most counties in the United States lack access to infectious diseases (ID) expertise. Developing an effective antimicrobial stewardship program (ASP) is challenging for many health care institutions, especially rural, community, and critical access hospitals with limited access to specialty care. Pharmacists are instrumental for the success of ASPs and pharmacy expertise is a requirement to meet federal ASP standards. Antimicrobial stewardship guidelines suggest telehealth consultation as an acceptable alternative to in‐person availability of an ID physician‐pharmacist team and encourage facilities to consider creative solutions for optimizing antimicrobial use. As a result, an understanding of successful telemedicine and tele‐ASP (TASP) models as a sustainable option is crucial. Data on existing TASP models, the role of clinical pharmacy services in TASPs, and future directions are herein described. Existing data on TASP are organized into three main categories of fully remote, integrated, or collaborative TASP models. TASPs may be led by remote ID physicians and/or ID‐trained clinical pharmacists within an affiliated health system or from an unaffiliated private practice, health system, or private telehealth entity. The on‐site stewardship pharmacist champion has a vital role in the success of many of the TASP models described by building trusting relationships with prescribers and key stakeholders, facilitating uptake of interventions and acceptance of the TASP, and ensuring timely therapy changes for patients. Future targets for TASP research should include TASP efforts in critical access hospitals and nonacute settings, the specific role of technology and clinical decision support software tools in TASP to improve and enhance pharmacist impact, and further descriptions of TASP models that improve patient‐centered outcomes.

show abstract

Section: Technology and Tele‐antimicrobial Stewardshipmentioning

confidence: 99%